Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (HK:1093)
HKEX:1093
Holding HK:1093?
Track your performance easily
1093 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$4.45 - HK$7.83
Previous CloseHK$5.27
Volume273.63M
Average Volume (3M)116.94M
Market Cap
HK$61.54B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)9.7
Beta0.92
Next Earnings
Nov 19, 2024EPS Estimate
HK$0.11Last Dividend Ex-Date
Oct 31, 2024Dividend Yield5.66%
Share Statistics
EPS (TTM)0.54
Shares OutstandingN/A
10 Day Avg. Volume95,152,238
30 Day Avg. Volume116,937,243
Standard Deviation0.11
R-Squared0.17
Alpha0.00116
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.85
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$7.78Price Target Upside47.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
CSPC Pharmaceutical Group News
PremiumCompany Announcements
CSPC Pharmaceutical Warns of Profit Decline Amid Drug Sales Challenges
PremiumCompany Announcements
CSPC Pharma Advances CAR-T Therapy for Myasthenia Gravis
PremiumCompany Announcements
CSPC Innovation Reports Declining Financial Performance
PremiumCompany Announcements
CSPC Pharmaceutical’s New Drug Wins China Approval
PremiumCompany Announcements
CSPC’s New Cancer Drug Accelerates Through FDA Fast TrackPremiumCompany Announcements
CSPC Pharma Signs Major Deal with AstraZeneca
PremiumCompany Announcements
CSPC Pharmaceutical Inks Major Licensing Deal in China
PremiumCompany Announcements
CSPC Pharmaceutical’s New Hypertension Drug Trials ApprovedBulls Say, Bears Say
Bulls Say
Dividend And Buyback StrategyThe share price correction has increased the dividend yield to approximately 6%, while incremental share buybacks are set to alleviate selling pressure.
Financial PerformanceGross profit margin improved impressively to 71.6%, boosted by increased revenue from finished drugs.
Growth PotentialInvestors are expected to gradually shift focus to new product sales ramp-up, projected to grow significantly by 52% annually in the coming years.
Bears Say
Earnings RiskFuture earnings face downside risks due to ongoing anti-corruption measures and the impact of VBP on major products.
Financial Performance2Q24 revenue and underlying profit were more than 10% below market expectations, impacted by weak oncology sales.
Product SalesSales targets for new products have been lowered because of delays in hospital listings.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.54% Mutual Funds
― Other Institutional Investors
89.74% Public Companies and
Individual Investors
1093 FAQ
What was CSPC Pharmaceutical Group Limited’s price range in the past 12 months?
CSPC Pharmaceutical Group Limited lowest stock price was HK$4.45 and its highest was HK$7.83 in the past 12 months.
What is CSPC Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is CSPC Pharmaceutical Group Limited’s upcoming earnings report date?
CSPC Pharmaceutical Group Limited’s upcoming earnings report date is Nov 19, 2024 which is in 14 days.
How were CSPC Pharmaceutical Group Limited’s earnings last quarter?
CSPC Pharmaceutical Group Limited released its earnings results on Aug 21, 2024. The company reported HK$0.131 earnings per share for the quarter, missing the consensus estimate of HK$0.154 by -HK$0.023.
Is CSPC Pharmaceutical Group Limited overvalued?
According to Wall Street analysts CSPC Pharmaceutical Group Limited’s price is currently Undervalued.
Does CSPC Pharmaceutical Group Limited pay dividends?
CSPC Pharmaceutical Group Limited pays a Annually dividend of HK$0.16 which represents an annual dividend yield of 5.66%. See more information on CSPC Pharmaceutical Group Limited dividends here
What is CSPC Pharmaceutical Group Limited’s EPS estimate?
CSPC Pharmaceutical Group Limited’s EPS estimate is HK$0.11.
How many shares outstanding does CSPC Pharmaceutical Group Limited have?
CSPC Pharmaceutical Group Limited has 11,695,882,000 shares outstanding.
What happened to CSPC Pharmaceutical Group Limited’s price movement after its last earnings report?
CSPC Pharmaceutical Group Limited reported an EPS of HK$0.131 in its last earnings report, missing expectations of HK$0.154. Following the earnings report the stock price went down -5.648%.
Which hedge fund is a major shareholder of CSPC Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:1093
---
CSPC Pharmaceutical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.33%
12-Months-Change
Fundamentals
Return on Equity
17.87%
Trailing 12-Months
Asset Growth
9.64%
Trailing 12-Months
Company Description
CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
---
1093 Stock 12 Month Forecast
Average Price Target
HK$7.78
▲(47.55% Upside)
Technical Analysis
Best Analysts Covering 1093
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-11.28%
reiterated a buy rating 2 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -11.28% per trade.
---